SentiSense
Ctrl+K
Quick tip: Press
to search stocks
J
JNJ
Johnson & Johnson
$241.52
-0.52 (-0.21%)
Summary
Stories
News
Metrics
Fundamentals
Holders
Full institutional holders data is a Pro feature
UpgradeInstitutional Holders
4128
tracked filers
Total Institutional Value
$151.4B
4128 holders tracked
Report Date
Q4 2025
SEC 13F-HR filing
| Holder | Category | Shares | Value | Weight | Change |
|---|---|---|---|---|---|
STATE STREET CORP | Index Fund | 132.2M | $24.5B | -- | -0.5% |
GEODE CAPITAL MANAGEMENT, LLC | Index Fund | 49.3M | $9.1B | -- | -8.6% |
NORGES BANK | Sovereign Wealth | 29.0M | $4.7B | -- | -9.1% |
WELLINGTON MANAGEMENT GROUP LLP | Other | 25.1M | $4.7B | -- | +4.3% |
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | Insurance | 21.8M | $4.0B | -- | -- |
Data source: SEC EDGAR 13F-HR filings
Company Profile
Symbol
JNJ
Market Cap
$583.29B
IPO Date
Sep 25, 1944
CEO
Joaquin Duato
Employees
140,800
Sector
--
Industry
PHARMACEUTICAL PREPARATIONS
Country
United States
Exchange
--
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Read MoreSimilar Stocks
PFE
Pfizer Inc.
$26.58
-1.04%
ABBV
AbbVie Inc.
$219.68
-2.52%
VTRS
Viatris Inc.
$13.51
-2.10%
PG
Procter & Gamble Company
$150.65
+0.10%